SCHEMBL24169276

SCHEMBL24169276

CCCOc1ccc(Cc2nnn[nH]2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.57
▸ LMNA P02545 5/20 0.49
▸ HTT P42858 3/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ NPC1 O15118 5/20 0.46
▸ RAB9A P51151 5/20 0.46
▸ L3MBTL1 Q9Y468 5/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ DHFR P00374 1/20 0.45
▸ PLA2G2A P14555 1/20 0.44
▸ HPGD P15428 1/20 0.42
▸ CACNA2D1 P54289 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP19A1 P11511 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9570634 0.88 PLA2G2A (0.46) MAPTLMNAHTTNPC1RAB9A
SCHEMBL5727055 0.85 MAPT (0.40) MAPTLMNAHTTHSD17B10NPC1
SCHEMBL6150323 0.81 LTA4H (0.47) MAPTLMNASMN1; SMN2KDM4EHPGD
SCHEMBL11534430 0.80 DAO (0.33) NPC1RAB9AGAA
SCHEMBL13946889 0.79 TP53 (0.41) NPC1RAB9ASMN1; SMN2TP53CYP1A2
SCHEMBL12869123 0.77 LMNA (0.49) MAPTLMNANPC1RAB9AL3MBTL1
SCHEMBL8844670 0.77 LTA4H (0.40) MAPTHTTL3MBTL1CYP1A2CYP2C9
SCHEMBL2495606 0.76 LMNA (0.62) MAPTLMNAHTTHSD17B10L3MBTL1
SCHEMBL8534048 0.75 GRIN1 (0.52) LTA4H
SCHEMBL6494392 0.75 RAB9A (0.56) MAPTLMNAHSD17B10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2023-06-29 — — US disclosed
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2023-06-29 — — US disclosed
US-11654146-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2023-05-23 — — US disclosed
US-11654146-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2023-05-23 — — US disclosed
US-11654146-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2023-05-23 — — US disclosed
US-20210401843-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2021-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11654146-B2 Methods for killing antibiotic tolerant bacteria CLPP, SPOUT1, CASP3 MAPT 4525/4885LMNA 4006/4885HTT 4278/4885
US-20210401843-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA CLPP, SPOUT1, CASP3 MAPT 4525/4885LMNA 4006/4885HTT 4278/4885
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA CLPP, SPOUT1, CASP3 MAPT 4525/4885LMNA 4006/4885HTT 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback